Faeth Therapeutics, Inc. Embedded Derivative, Fair Value of Embedded Derivative Asset
Faeth Therapeutics, Inc. (FTH) had Embedded Derivative, Fair Value of Embedded Derivative Asset of $0 as of 2020-12-31, per its 10-K filed 2022-03-15.
Discontinued › Notes
us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeAsset · last filed 2022-03-15
- 2020-12-31: Embedded Derivative, Fair Value of Embedded Derivative Asset $0.00.
- 2020-09-30: Embedded Derivative, Fair Value of Embedded Derivative Asset $0.00.
- 2020-06-30: Embedded Derivative, Fair Value of Embedded Derivative Asset $0.00.
| Period end | Embedded Derivative, Fair Value of Embedded Derivative Asset |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |